Eosinophilic granulomatosis with polyangiitis with heterozygous familial hypercholesterolemia: A tricky therapeutic approach with omalizumab and evolocumab

Nutr Metab Cardiovasc Dis. 2023 Feb;33(2):461-464. doi: 10.1016/j.numecd.2022.12.015. Epub 2022 Dec 24.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Churg-Strauss Syndrome* / drug therapy
  • Granulomatosis with Polyangiitis* / drug therapy
  • Humans
  • Omalizumab / therapeutic use

Substances

  • Omalizumab
  • evolocumab
  • Antibodies, Monoclonal, Humanized